bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.10.25.761689

GLESKit: an MCP-based system for gene-level biomedical investigation and evidence synthesis

Moraes, A.·Ferreira, P. G.
View original source ↗Export metadata ↓

Abstract

Biomedical investigation at the gene level requires researchers to combine expression data, functional annotations, pathways, interaction networks, genetic associations, drug evidence and literature. Accessing these resources involves databases, analysis tools and scripts that require bioinformatics expertise, complicating the production of clear, reviewable reports. We present GLESKit, a gene centred system that connects these steps through the Model Context Protocol and retains data, analyses, sources and reports within a study workspace. We evaluated report production with 15 author curated GeneReportBench tasks and question answering with a gene level subset of BixBench, a reference biology benchmark for agentic systems. GLESKit completed all 15 reports with a mean committee score of 0.904, although evidence quality varied, and earned positive credit on 35 of 39 scored human BixBench questions with a mean of 0.438. In paired tests, configurations with skills scored 0.145 higher across 20 questions and 0.085 higher across five reports.

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Moraes, A., Ferreira, P. G.. 2026-10-30. GLESKit: an MCP-based system for gene-level biomedical investigation and evidence synthesis. https://doi.org/10.64898/2026.10.25.761689

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

EMBER: Contextualized gene representations enable compositional prediction across cellular perturbations

Predicting the effects of individual and combined perturbations is central to identifying context-specific vulnerabilities and designing targeted interventions. Yet learning gene representations that integrate functional relationships with cellular state and transfer across perturbation tasks remains challenging. Here, we present EMBER, a gene-centric foundation model that learns context-dependent functional representations of genes. EMBER combines interaction-guided contrastive learning with masked expression reconstruction during pretraining on a single-cell corpus curated for diversity and balanced sampling across cell types and experimental batches. EMBER decouples gene representation learning from task-specific prediction through a composable embedding framework: the pretrained encoder remains frozen, while lightweight probes combine contextualized gene embeddings to predict individual and combined perturbation effects. The same pretrained representations support single-gene perturbation-response prediction, digenic interaction prediction, and multi-target drug-response prediction. EMBER improves cross-context perturbation-response prediction and genetic-interaction ranking relative to evaluated baselines. EMBER also prioritized SCFD1, a mediator of autophagosome-lysosome fusion, as a candidate dependency during mTOR inhibition. Together, these results establish contextualized gene embeddings as reusable building blocks for modeling genetic and pharmacological perturbations, supporting the prioritization of genetic interactions and context-specific interventions for experimental testing.

bioinformatics↗
bioRxiv2026

Small molecule structure elucidation from NMR spectra with generative and reasoning models

Elucidating the structures of unknown small molecules remains a major challenge in chemistry, pharmacology, and drug discovery. While nuclear magnetic resonance (NMR) spectroscopy is the gold standard for structure elucidation, interpreting spectra remains labor-intensive and requires expert knowledge to navigate the vast space of possible structures. Here, we present an AI system for rapid, automated de novo structure elucidation that combines a molecular generative model with a scientific reasoning agent. Its generative component, ChefNMR2, is an atomic flow-matching model that predicts small-molecule structures from molecular formulae and one-dimensional 1H and 13C NMR spectra. ChefNMR2-Agent augments our generative model with large language models (LLMs) to reason over and refine candidate structures. Across diverse benchmarks, ChefNMR2 substantially outperforms existing tools, offering calibrated confidence estimates and two to three orders of magnitude faster inference than frontier LLMs. We use ChefNMR2-Agent to elucidate the structures of four novel natural products, matching human-chemist accuracy in a fraction of the time. Our work demonstrates how specialized generative models and general-purpose reasoning agents can unite to solve challenging scientific inverse problems and accelerate NMR structure elucidation, thus opening new possibilities for AI-driven small-molecule discovery across diverse disciplines.

bioinformatics↗
bioRxiv2026

Digital twins forecast individual immune trajectories

The human immune system differs markedly between individuals and changes in response to infection, vaccination and treatment. AI virtual cells are being built to simulate cellular responses to perturbation. Yet these models, like most immune-response predictors, describe each person by a single pre-challenge measurement and forecast change from patterns pooled across people. Digital twins, updated with every new observation of an individual, could forecast how that person's immune state changes. Here we present ImmuneTwins, which builds these twins from single-cell profiles by personalizing a shared virtual-cell model with each individual's observations. In two external populations, ImmuneTwins reduced immune-age error by 32% and 42% relative to the best existing method. During repeated influenza vaccination, its twins predicted the direction of immune-cell change 35% more accurately than the best published method, and their error fell by 27% as observations accumulated. The twins revealed that immune cells and plasma proteins recover about half their deviation from a persistent personal reference within 90 days, whereas response size varies between challenges. They further localized B-cell remodelling in exceptional longevity and anticipated patient-specific immune trajectories during myeloma treatment. These results establish virtual-cell digital twins for forecasting individual immune change and identifying each person's characteristic immune features.

bioinformatics↗